Taxotere Warnings Now Include Permanent Hair Loss

Despite warnings for a number of other side effects, permanent hair loss from using Taxotere was not originally included

Monday, June 19, 2017 - The Federal Food and Drug Administration has issued warnings to users of the anti-cancer drug Taxotere, advising them of the severity of the side effects of the drug, and has found the drug's manufacturer, Sanofi to be in violation of federal regulations. Despite Taxotere's causing permanent hair loss in approximately 10-15% of the patients that use it, the drug continues to be used extensively as chemotherapy for breast, neck, throat and other serious life-threatening cancers. Today, however, many physicians have been made aware of the drug's permanent hair loss side effects and are advising their patients of safer, less toxic alternatives.

The FDA has compiled information on Taxotere permanent hair loss. Research conducted by Sanofi in the 1990s and early 2000s shows that as many as 9% of patients taking Taxotere suffer from permanent hair loss. Adverse event reports support the findings that Taxotere hair loss is permanent in some persons. Hair loss is listed as an adverse reaction to Taxotere. The FDA now warns of permanent hair loss as well as loss of eyesight, and respiratory problems as being side effects of the drug.

Taxotere and Permanent Hair Loss

Reports filed by patients and physicians on side effects of Taxotere have produced volumes on Taxotere causing permanent hair loss. The company's own research dating back to the 1990's indicates that 10-15% of people using Taxotere develop permanent hair loss. Although hair loss has always been associated with chemotherapy, permanent hair loss has not been mentioned.

Sanofi in Violation of Federal Regulations

Sanofi was found to be in violation of federal Food and Drug Administration regulations when the company was found to have made unsubstantiated claims that Taxotere was more effective at fighting cancer than other drugs when in fact it is not. The FDA found that the company's claims were not grounded in scientific fact and thus the Sanofi had misbranded their product. A 2008 edition of the New England Journal of Medicine found a different anti-cancer drug, Taxol to be more effective in slowing the growth of certain cancers, less toxic, and not as of yet linked to permanent hair loss.

Taxotere Lawsuits

In 2005 Sanofi first acknowledged that their drug Taxotere was linked to permanent hair loss and chose to warn consumers in Canada and Europe of their findings. Rather than risk their $1.4 billion market monopoly, or damage their brand in any way, no changes to the existing product warning were made in the United States. It was not until a former employee whistleblower sued the company, accusing Sanofi of engaging in fraudulent marketing practices were the side effects of permanent hair loss brought to light in the US. Rather than warn doctors of the permanent hair loss side effects of Taxotere, the company stepped up its North American marketing efforts by paying grants, speaker fees, travel expenses and other perks to doctors as thanks for their loyalty in continuing to use their drug.

Many other have followed the lead of the 2005 Pennsylvania lawsuit and have filed lawsuits across the nation accusing Sanofi of blatantly disregarding FDA warnings and consumer safety needs. Through Taxotere lawsuits, those whose lives have been left in shambles by the company's negligence can hold Sanofi accountable for their illegal actions.

If you have suffered the life-altering and psychologically devastating side effects of permanent hair loss from taking Taxotere, you may be eligible to sue the company for reimbursement of medical expenses, lost wages, and pain and suffering. You may, in fact, face a lifetime of psychological therapy from the trauma that permanent hair loss has inflicted upon you. The resultant stress disorders you may suffer may have caused you to lose your job and be left unable to find a new one. The personality and mood changes that have accompanied your post-treatment stress may have caused damage to your relationships and your marriage. It is up to you to hold Sanofil accountable for the pain and suffering that they have caused. Call the Taxotere lawyers at The Onder Law Firm today for a free consultation.

More Recent Taxotere Hair Loss Lawsuit News:

• Taxotere Alopecia Warning Limited to the Fine Print | 5/17/2019
• Women that have to undergo chemotherapy for the first time face great anxiety | 5/6/2019
• Taxotere Patients Denied Their Right To Make An Informed Decision | 4/24/2019
• Patients Must Be Made Aware Of Taxotere's Three Major Side Effects | 4/18/2019
• Women Are Angry Over Sanofi Failing To Warn About The Possibility of Permanent Hair Loss | 4/12/2019
• Women Undergoing Cancer Treatments Are Taking Better Care of Themselves to Limit Hair Loss | 4/5/2019
• Taxotere Permanent Hair Loss Has Devastating Psychological Implications For Patients | 3/25/2019
• Taxotere Causes Alopecia Which Can Be Psychologically Damaging | 3/20/2019
• Drug Makers Need To Write Clearer, More Descriptive Drug Warnings Starting With Taxotere | 3/18/2019
• Taxotere Lawsuits May Teach Doctors a Valuable Lesson | 3/13/2019
• Taxotere Permanent Baldness Warning | 4/30/2018
• Taxotere Chemotherapy and Permanent Hair Loss | 4/26/2018
• Sanofi Sales Representatives Oversold Taxotere | 4/24/2018
• Scientific Study Confirms Permanent Taxotere Hair Loss | 4/12/2018
• Chemotherapy Drug Side Effects | 4/9/2018
• Cancer Doctors Fail to Warn Patients | 4/4/2018
• Taxotere's Psychological Side Effects | 3/13/2018
• Permanent Hair Loss Can Lead to Depression | 3/6/2018
• A Woman's Hair is Linked to Their Feminity | 2/23/2018
• Studies Indicate Taxotere Causes Permanent Hair Loss | 2/14/2018
• Taxotere's Ambiguous Hair Loss Warning | 2/5/2018
• Permanent Hair Loss Makes the Fear of Growing Old All Too Real | 12/29/2017
• Thousands of Women File Taxotere Hair Loss Lawsuits | 12/27/2017
• Taxotere Patients Psychological Trauma Result in Lawsuits Against Sanofi-Aventis | 12/22/2017
• Scientific Studies Point to Taxotere Hair Loss | 12/18/2017
• Cancer Patients Right to Make an Informed Decision | 12/13/2017
• How Women Think About Chemotherapy Hair Loss | 12/11/2017
• The Emotional Side Effects of Alopecia | 12/8/2017
• Taxotere May Cause Permanent Hair Loss | 12/4/2017
• Women Equate Baldness With Masculinity | 11/27/2017
• Symptoms of Permanent Hair Loss | 11/21/2017
• Taxotere's Warning May Have Come Too Late For Many | 11/15/2017
• Taxotere Benefits and Side Effects | 11/9/2017
• Women Were Not Given a Choice of Cancer Drugs | 11/1/2017
• The Impact of Permanent Hair Loss on Some Cancer Survivors | 9/29/2017
• The Emotional Side Effects of Permanent Hair Loss For Women Are All Too Real | 9/22/2017
• Taxotere is Highly Toxic and Causes Permanent Hair Loss | 9/15/2017
• 10-15 Percent of Cancer Patients Given Taxotere Develop Permanent Hair Loss | 9/8/2017
• Permanent Hair Loss From Taxotere is a Real Possibility | 9/1/2017
• Taxotere Permanent Hair Loss Lawsuits | 7/21/2017
• Permanent Hair Loss Caused by Taxotere | 6/26/2017
• Taxotere Hair Loss Lawsuits Focus on Warning Label | 6/12/2017
• Permanent Hair Loss in Some Taxotere Users Delivers Secondary Blow to Cancer Patients | 6/5/2017

Lawyers for Taxotere Hair Loss Lawsuits

Onder, Shelton, O'Leary & Peterson, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O'Leary & Peterson has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.